Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: A systematic review and meta-analysis

被引：0
|
作者：
Schipilliti, F. M. [1 ]
Rizzo, A. [2 ]
Di Costanzo, F. [3 ]
Acquafredda, S. [4 ]
Arpino, G. [5 ]
Puglisi, F. [6 ]
Del Mastro, L. [7 ]
Montemurro, F. [8 ]
De Laurentiis, M. [9 ]
Giuliano, M. [10 ]
机构：
[1] St Andrea Univ Hosp, Dept Oncol, Rome, Italy
[2] Ist Tumori Bari Giovanni Paolo II IRCCS, Dept Oncol, Bari, Italy
[3] Azienda Osped Univ Federico II, Oncol Med, Naples, Italy
[4] Policlin Bari Osped Giovanni XXIII, Dipartimento Oncol, Bari, Italy
[5] Univ Napoli Federico II, Dept Oncol, Dipartimento Farm, Naples, Italy
[6] Osped S Maria Misericordia, Dept Med Oncol, ASU Friuli Cent, Udine, Pordenone, Italy
[7] IRCCS Osped Policlin San Martino, Dept Internal Med, Genoa, Italy
[8] IRCCS Ist Candiolo FPO, Investigat Clin Oncol Dept, Candiolo, TO, Italy
[9] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Breast & Thorac Oncol, Naples, Italy
[10] AOU Federico II, Dept Oncol, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
266P
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [1] Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis
    Rizzo, A.
    Schipilliti, F. M.
    Di Costanzo, F.
    Acquafredda, S.
    Arpino, G.
    Puglisi, F.
    Del Mastro, L.
    Montemurro, F.
    De Laurentiis, M.
    Giuliano, M.
    ESMO OPEN, 2023, 8 (06)
  • [2] Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis
    Lin, Ying-Yi
    Gao, Hong-Fei
    Yang, Xin
    Zhu, Teng
    Zheng, Xing-xing
    Ji, Fei
    Zhang, Liu-Lu
    Yang, Ci-Qiu
    Yang, Mei
    Li, Jie-Qing
    Cheng, Min-Yi
    Wang, Kun
    BREAST, 2022, 66 : 126 - 135
  • [3] Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis
    Rizzo, Alessandro
    Cusmai, Antonio
    Massafra, Raffaella
    Bove, Samantha
    Comes, Maria Colomba
    Fanizzi, Annarita
    Rinaldi, Lucia
    Acquafredda, Silvana
    Gadaleta-Caldarola, Gennaro
    Oreste, Donato
    Zito, Alfredo
    Giotta, Francesco
    Lorusso, Vito
    Palmiotti, Gennaro
    CELLS, 2022, 11 (12)
  • [4] The relative risk of pneumonitis associated with neoadjuvant chemoimmunotherapy use in early-stage triple-negative breast cancer: A systematic review and meta-analysis
    Jahan, Nusrat
    Rehman, Shabnam
    Meda, Srikala
    Tijani, Lukman
    CANCER RESEARCH, 2022, 82 (04)
  • [5] Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
    Poggio, F.
    Bruzzone, M.
    Ceppi, M.
    Ponde, N. F.
    La Valle, G.
    Del Mastro, L.
    de Azambuja, E.
    Lambertini, M.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1497 - 1508
  • [6] Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis
    Petrelli, Fausto
    Ghidini, Antonio
    Rea, Carmen
    Parati, Maria Chiara
    Borgonovo, Karen
    Ghidini, Michele
    Ruatta, Fiorella
    Zaniboni, Alberto
    Luciani, Andrea
    Garrone, Ornella
    Tomasello, Gianluca
    CURRENT PROBLEMS IN CANCER, 2024, 50
  • [7] Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
    Li, Zhen-Yu
    Zhang, Zhen
    Cao, Xiao-Zhong
    Feng, Yun
    Ren, Sha-Sha
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
  • [8] Relative risk of various endocrinopathies associated with the use of chemoimmunotherapy for triple-negative breast cancer: A systematic review and meta-analysis
    Jahan, Nusrat
    Wongsaengsak, Sariya
    Singal, Sakshi
    Rehman, Shabnam
    Hardwicke, Fred
    Jones, Catherine
    CANCER RESEARCH, 2021, 81 (04)
  • [9] Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis
    Hercules, Shawn M.
    Alnajar, Meena
    Chen, Chen
    Mladjenovic, Stefan M.
    Shipeolu, Bolade Ajarat
    Perkovic, Olga
    Pond, Greg R.
    Mbuagbaw, Lawrence
    Blenman, Kim R. M.
    Daniel, Juliet M.
    BMJ OPEN, 2022, 12 (05): : e055735
  • [10] MicroRNAs in the prognosis of triple-negative breast cancer A systematic review and meta-analysis
    Lu, Lingshuang
    Mao, Xuhua
    Shi, Peiyi
    He, Biyu
    Xu, Kun
    Zhang, Simin
    Wang, Jianming
    MEDICINE, 2017, 96 (22)
12345